24th Nov 2008 11:58
Ark Therapeutics Group plc
24 November 2008
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS
1. Name of the issuer
Ark Therapeutics Group PLC
2. State whether the notification relates to
(i) a transaction notified in accordance with DR 3.1.4R(1)(a); or
(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or
(iii) both (i) and (ii)
(ii) Director
3. Name of person discharging managerial responsibilities/director
Andrew Christie
4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person
N/A
5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest
Beneficial holding of the person indicated in 3 above
6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares
1 pence ordinary shares
7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them
Andrew Christie
8 State the nature of the transaction
Purchase of shares
9. Number of shares, debentures or financial instruments relating to shares acquired
12,658
10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)
0.006%
11. Number of shares, debentures or financial instruments relating to shares disposed
N/A
12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)
N/A
13. Price per share or value of transaction
39.5 pence
14. Date and place of transaction
21 November 2008, UK
15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)
12,658 (0.006%)
16. Date issuer informed of transaction
21 November 2008
17. Any additional information
N/A
18. Name of contact and telephone number for queries
Martyn Williams 020 7388 7722
Name of duly authorised officer of issuer responsible for making notification
Martyn Williams
Date of notification
24 November 2008
Related Shares:
PVG.L